Clinical Trial Results Home

STEMI: Primary PCI

Primary PCI
Intracoronary Therapy
 Primary PCI

ALKK: Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte

      -PTCA in stable survivors of acute MI vs medical therapy

BRAVE-2: Bavarian Reperfusion Alternatives Evaluation 2

      -Benefit of primary PCI among asymptomatic pts presenting late in STEMI by Dr. Adnan Kastrati (ACC 2005)

CADILLAC: Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications Trial

      -Abciximab & Bare Metal Stenting in STEMI

CAPTIM: Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction

      -One-Year Results

DANAMI II: DANish trial in Acute Myocardial Infarction-2

      -Trial Overview by Dr. Henning Rud Anderson (ACC 2002)

HORIZONS-AMI: Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction

      -Predictors of Acute, Subacute and Late Stent Thrombosis after Acute MI Primary Angioplasty in the Horizons AMI Trial by Dr. George Dangas


HORIZONS-SWITCH Analysis: Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction

      -Trial Overview by Dr. George Dangas

MATE: Medicine vs Angiography in Thrombolytic (Reperfusion) Exclusion Patients

      -A Prospective Randomized Trial of Triage Angiography in Suspected Acute Myocardial Infarction Patients Who Are Considered Ineligible for Reperfusion Therapy by Dr. Peter McCullough

NORDISTEMI: NORwegian Study on District treatment of ST-Elevation Myocardial Infarction

      -Immediate Angioplasty Compared to Ischemia-Guided Management After Thrombolysis for ST-Elevation Myocardial Infarction in Areas with Very Long Transfers by Dr. Sigrun Halvorsen

PAMI Stent: Primary Angioplasty in Myocardial Infarction Stent trial

      -6 Month Results

      -1 Year Results

      -Mortality among patients with a closed artery on presentation to cath lab

PASEO: Paclitaxel- or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty

      -Long-term Outcome of Drug-eluting Stents Compared with Bare Metal Stents in ST-segment Elevation Myocardial Infarction by Dr. Emilio Di Lorenzo, et al.


PROTECTION AMI: Selective Inhibition of Delta Protein Kinase C to Reduce Infarct Size after Primary Percutaneous Intervention for Acute Myocardial Infarction

      -Trial Overview by Dr. A Michael Lincoff  (ACC 2011)

RELAx-AMI: Randomized Early versus Late Abciximab in Acute Myocardial Infarction Treated with Primary Coronary Intervention Trial

      -Trial Overview by Dr. Mauro Maioli


REVERSE STEMI: Interventionalist Versus Patient Transfer Strategies for Primary Percutaneous Coronary Intervention in Patients with Acute ST-Eevation Myocardial Infarction

      -One Year Trial Results by Dr. Wei Feng Shen

SESAMI Trial: Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction

      -Randomized trial of Sirolimus Stent vs Bare Stent in Acute Myocardial Infarction by Dr. Maurizio Menichelli


STEMI-RADIAL: Radial vs. Femoral Access in Patients with ST-Segment Elevation Myocardial Infarction

      -Trial Overview by Dr. Ivo Bernat (TCT 2012)


WEST: Which Early ST-Elevation Myocardial Infarction Therapy Trial

      -Trial Overview by Dr. Paul W. Armstrong

(Return to Contents)

 Intracoronary Therapy

AIDA STEMI MRI: Cardiac MRI Substudy from a Prospective, Randomized Trial of Intracoronary Abciximab in Patients with ST-Segment Elevation Myocardial Infarction

      -Study Overview by Dr. Holger Thiele (TCT 2012) 


CICERO: Intracoronary Versus Intravenous Abciximab in ST-Elevation Myocardial Infarction

      -Trial Results in Patients Undergoing Primary Percutaneous Coronary Intervention with Thrombus Aspiration by Dr. Youlan L. Gu (AHA 2010)


CRYSTAL AMI: Intracoronary Site-Specific Abciximab Compared to Intravenous Abciximab in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasy

       -A Prospective Randomized Trial of Intracoronary Site-Specific Abciximab Compared to Intravenous Abciximab in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasy by Dr. Rajesh M. Dav

       -Pilot Trial Results by Dr. Saihari Sadanandan (C3 Complex Intervention Meeting 2011)

COCTAIL Study: Optimal Treatment of Intracoronary Thrombosis with Local Abciximab Infusion Through the Clearway System

      -Trial Overview by Dr. Francesco Prati (TCT 2009)

ICSK after Primary PCI

      -Intracoronary Streptokinase After Primary Percutaneous Coronary Intervention by Dr. Murat Sezer


INFUSE-AMI: A 2x2 Factorial, Multicenter, Prospective, Randomized Evaluation of Intracoronary Abciximab and Aspiration Thrombectomy in Patients Undergoing Primary PCI for Anterior STEMI.

      -Trial Overview by Dr. Gregg W. Stone (ACC 2012)


SCAAR: Non-randomized Comparison from SCAAR of Eptifibatide of Abciximab in Primary PCI for STEMI

      -Results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) by Dr. Axel Akerblom


(Return to Contents)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at For further information please see the Policy section. Webmaster